NCT00006105View on ClinicalTrials.gov

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

November 30, 2004

Study Completion Date

September 30, 2006

Conditions
Bladder CancerDrug/Agent Toxicity by Tissue/Organ
Interventions
DRUG

amifostine trihydrate

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

PROCEDURE

adjuvant therapy

Trial Locations (1)

60637-1470

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00006105 - Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter